Hangzhou Frenovo Biotech aims to be the leader in vitro rapid lateral flow test, dominate the market for disease diagnosis and analyte detection. We dedicated to producing world class high quality test kits.
Covid-19 related tests are launched! Covid-19 antigen and Flu A+B
We already gained CE certificate for covid-19 antigen and antibody tests and Flu A and B tests.
Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract. It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the fall and winter months. Type A viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B infections are usually milder. The gold standard of laboratory diagnosis is 14-day cell culture with one of a variety of cell lines that can support the growth of influenza virus. Cell culture has limited clinical utility, as results are obtained too late in the clinical course for effective patient intervention. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a newer method that is generally more sensitive than culture with improved detection rates over culture of 2-23%. However, RT-PCR is expensive, complex and must be performed in specialized laboratories.
The novel corona-viruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel corona- virus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
FRENOVO FLU A+B & COIVD-19 antigen rapid test qualitatively detects the presence of Influenza A and/or Influenza B antigen in nasal swab or throat swab or nasal aspirate specimens, providing results within 15 minutes.
COVID-19 IgG/IgM rapid tests are launched！
The 2019-NCoV is a large family of viruses known to cause colds as well as more serious illnesses such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Novel coronavirus is a novel coronavirus strain that has never been found in humans before.
In more severe cases, infection can lead to pneumonia, severe acute respiratory syndrome, kidney failure and even death. FRENOVO COVID-19 IgG/IgM rapid test (Whole Blood/ Serum/ Plasma) is a rapid test that utilizes a combination of COVID-19 antigen coated colored particles for the qualitative detection of IgG and IgM antibodies to COVID-19 in human whole blood, serum, or plasma as an aid in the diagnosis of primary and secondary COVID-19 infections.
In Vitro Diagnosis (IVD) refers to the process of taking blood, body fluid and tissue samples out of the body for Diagnosis. IVD is playing an increasingly important role in modern society, and currently it is used in more than 80% of clinical diagnosis of diseases. It plays an extremely important r
Influenza viruses belong to orthomyxoviriaceae in virology. Its genetic material consists of 8 independent single-stranded negative strand RNA fragments of different sizes, encoding 10 proteins in total. Its characteristic is prone to mutation. It is divided into three types: A, B and C, among which
Lateral flow immunochromatography assay(LFIA) is a classical point of care testing (POCT) based on the immune responses of antigens and antibodies. Initially, the researchers used nanometer gold to prepare chromatographic strips for urinary human chorionic gonadotropin detection, known as colloidal
In 1983, an American named Mullis invented the technology of polymerase chain reaction (PCR). This technology takes advantage of the principle of DNA denaturation and renaturation, uses warm extend, heat denaturation and renaturation at low temperature, which makes DNA fragments in vitro amplificati
The global epidemic continues to spread. In the Americas, the U.S. Centers for Disease Control and Prevention predicts that there will be 230,000 deaths in the United States by the end of October. A school in Brazil was closed again just three days after it reopened. In Europe, the number of new cas
Hangzhou Frenovo Biotech Co., Ltd. is delicated to R&D and manufacturing of diagnostic test kit with a bunch of exprienced and educated scientists. Located in Zhejiang and founded in 2020, we bear in our mind that high quality and affordable products for clients is essential.
Hangzhou Frenovo Biotech Co., Ltd, also offer customized services. Customized test kits, like sheet's dimension, materials, such as antibodies, antigens, membrance, pads are highly welcomed.
Hangzhou Frenovo Biotech Co., Ltd. have years of efforts on numerous exploratory experiments and mass production practice.